DeepMed Research

RUTGERS, THE STATE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Effects of Hydrocortisone in Endotoxemia in Normal Volunteers

Phase 1

Completed

Conditions: Infections

Interventions: Biological: Endotoxin, Lipopolysaccharide, LPS
Biological: Endotoxin, Lipopolysaccharide, LPS /Epinephrine
Biological: Placebo
Biological: Hydrocortisone

First Posted Date: 2010-02-09

Last Posted Date: 2014-05-22

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 12

Registration Number: NCT01064986

Locations: 🇺🇸
Rutgers-RWJMS, New Brunswick, New Jersey, United States

Internet-Based Weight-Loss Program for Colorectal Cancer Survivors

Not Applicable

Withdrawn

Conditions: Cancer Survivor
Colorectal Cancer
Weight Changes

Interventions: Behavioral: Internet weight loss intervention

First Posted Date: 2009-12-15

Last Posted Date: 2017-03-06

Lead Sponsor: Rutgers, The State University of New Jersey

Registration Number: NCT01032590

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Isoflurane Preconditioning for Liver Resections

Not Applicable

Terminated

Conditions: Liver Disease

Interventions: Drug: propofol
Drug: isoflurane

First Posted Date: 2009-12-14

Last Posted Date: 2017-03-20

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 8

Registration Number: NCT01031550

Locations: 🇺🇸
UMDNJ-University Hospital, Newark, New Jersey, United States

Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Phase 1

Terminated

Conditions: Metastatic Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: riluzole
Radiation: whole-brain radiation therapy

First Posted Date: 2009-11-25

Last Posted Date: 2014-05-02

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 9

Registration Number: NCT01018836

Locations: 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia

Phase 4

Completed

Conditions: Smoking Cessation
Schizophrenia

Interventions: Drug: Nicotine Nasal Spray
Behavioral: Behavioral counseling

First Posted Date: 2009-11-10

Last Posted Date: 2014-09-08

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 66

Registration Number: NCT01010477

Locations: 🇺🇸
Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies

Phase 2

Terminated

Conditions: Leukemia

Interventions: Drug: 12-O-tetradecanoylphorbol-13-acetate
Drug: Dexamethasone
Drug: Choline magnesium trisalicylate

First Posted Date: 2009-11-09

Last Posted Date: 2015-11-04

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 1

Registration Number: NCT01009931

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Phase 2

Completed

Conditions: Colorectal Cancer

Interventions: Drug: hydroxychloroquine

First Posted Date: 2009-11-01

Last Posted Date: 2021-09-21

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 38

Registration Number: NCT01006369

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸
Cooper Hospital/University Medical Center, Camden, New Jersey, United States
🇺🇸
Cancer Institute of New Jersey at Hamilton, Hamilton, New Jersey, United States

and more 1 locations

Dexmedetomidine Versus Propofol in Vitreoretinal Surgery

Phase 4

Completed

Conditions: Retinal Detachment

Interventions: Drug: Dexmedetomidine infusion
Drug: propofol

First Posted Date: 2009-10-26

Last Posted Date: 2017-08-21

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 78

Registration Number: NCT01001429

Locations: 🇺🇸
UMDNJ-University Hospital, Newark, New Jersey, United States
🇺🇸
University Hospital, Newark, New Jersey, United States

Measurement of Pro-angiogenic Markers in Patients With Hepatic Metastases Undergoing SIRT

Completed

Conditions: Liver Cancer

First Posted Date: 2009-10-14

Last Posted Date: 2014-03-20

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 36

Registration Number: NCT00994370

Locations: 🇺🇸
Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States

Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate

Terminated

Conditions: Prostate Cancer

First Posted Date: 2009-10-08

Last Posted Date: 2021-04-08

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 126

Registration Number: NCT00991315

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy